<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mansonella infections</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mansonella infections</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mansonella infections</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amy D Klion, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 22, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4462369"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Three species of <em>Mansonella</em> cause human infections: <em>M. streptocerca</em>, <em>M. perstans</em>, and <em>M. ozzardi</em>. Each species has a limited geographic distribution and typically causes mild symptoms if any at all. A potential fourth species, <em>Mansonella </em>spp "DEUX", that is morphologically similar to <em>M. perstans</em> has been detected by molecular genotyping in blood samples of individuals in Gabon; the clinical relevance of this finding remains uncertain [<a href="#rid1">1</a>]. </p><p>The epidemiology, clinical features, diagnosis, and treatment of <em>Mansonella</em> infections will be reviewed here (<a class="graphic graphic_table graphicRef66052 graphicRef70668" href="/d/graphic/66052.html" rel="external">table 1A-B</a>). Other filarial infections, including loiasis, onchocerciasis, and lymphatic filariasis, are discussed separately. (See  <a class="medical medical_review" href="/d/html/5683.html" rel="external">"Onchocerciasis"</a> and  <a class="medical medical_review" href="/d/html/5675.html" rel="external">"Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5680.html" rel="external">"Lymphatic filariasis: Treatment and prevention"</a> and  <a class="medical medical_review" href="/d/html/5684.html" rel="external">"Loiasis (Loa loa infection)"</a>.)</p><p class="headingAnchor" id="H4462376"><span class="h1">MANSONELLA PERSTANS</span></p><p class="headingAnchor" id="H4462384"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span><em>M. perstans</em> is endemic in a large portion of sub-Saharan Africa, from Senegal to Uganda and south to Zimbabwe, and in Central and South America, from Panama to Argentina (<a class="graphic graphic_figure graphicRef101816" href="/d/graphic/101816.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef101817" href="/d/graphic/101817.html" rel="external">figure 2</a>) [<a href="#rid2">2</a>]. Since the majority of infected individuals are asymptomatic and diagnosis is typically based on morphologic examination of blood microfilariae, the epidemiology of <em>M. perstans</em> has not been clearly defined. Nevertheless, it has been estimated that 114 million people may be infected and as many as 581 million people in 33 countries are at risk for <em>M. perstans</em> infection in Africa alone [<a href="#rid2">2</a>]. Molecular analyses suggest that reports of atypical blood microfilariae in residents of the Amazon regions of Brazil and Peru, which were originally thought to be <em>M. perstans</em>, are actually <em>M. ozzardi</em> [<a href="#rid3">3,4</a>]; however, a study has confirmed the presence of both parasites in this region, as well as coinfection with the two parasites in two individuals tested [<a href="#rid5">5</a>]. (See <a class="local">'Mansonella ozzardi'</a> below.)</p><p>In endemic regions, the probability of infection increases with age, with prevalences reaching 100 percent in highly endemic areas. Infection of travelers is uncommon but it does occur [<a href="#rid6">6,7</a>]. Data from Gabon suggest a higher prevalence of <em>M. perstans</em> microfilaremia in people living with human immunodeficiency virus (HIV) infection [<a href="#rid8">8</a>]. Nonhuman primates are occasionally infected with <em>M. perstans</em> but do not appear to be a major reservoir of infection.</p><p><em>M. perstans</em> is transmitted by biting midges (<em>Culicoides</em>). The life cycle is similar to that of other filariae (<a class="graphic graphic_figure graphicRef82920" href="/d/graphic/82920.html" rel="external">figure 3</a>). Infective larvae introduced during the bite of an infected midge mature over months into adult worms. The adult worms live in the pleural, pericardial, and peritoneal cavities as well as the mesenteric, perirenal, and retroperitoneal tissues, where they produce unsheathed microfilariae that are found in the bloodstream at all times. Microfilariae are responsible for transmission of infection because they are taken up during the blood meal of the insect vector. The life cycle is completed following maturation of microfilariae into infective third-stage larvae within the midge. The lifespan of the adult worms is unknown, although microfilaria-positive cases have been reported up to 10 years after the infected individual has left the endemic area [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H4462398"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Most individuals with <em>M. perstans</em> infection are asymptomatic [<a href="#rid7">7,10,11</a>], although nonspecific symptoms including pruritus, urticaria, arthralgia, abdominal pain, and fatigue reported in patients with <em>M. perstans</em> microfilaremia are often attributed to concomitant infections. When more characteristic symptoms do occur, they are predominantly related to migration of the adult worms and include transient subcutaneous swellings similar to the Calabar swellings of <em>Loa loa</em> infection, serositis (ie, pericarditis and pleuritis), and ocular symptoms (granulomatous nodules in the conjunctiva, retinal lesions, and periorbital inflammation surrounding dead adult worms). Neuropsychiatric manifestations, meningoencephalitis, and hepatitis have also been described.</p><p>Nonspecific but characteristic laboratory abnormalities include eosinophilia and elevated serum immunoglobulin (Ig)E levels.</p><p class="headingAnchor" id="H4462405"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span><em>M. perstans</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, consistent clinical findings, and/or unexplained eosinophilia. The definitive diagnosis is established by identifying the adult worm in tissues or microfilariae in the blood. Serology may also be useful.</p><p class="headingAnchor" id="H4462412"><span class="h3">Visualizing organisms</span><span class="headingEndMark"> — </span>The diagnosis of <em>M. perstans</em> infection can be definitively established by detecting microfilariae in a blood smear (<a class="graphic graphic_picture graphicRef83928" href="/d/graphic/83928.html" rel="external">picture 1</a>) or, rarely, by the identification of adult worms in tissue specimens. Microscopy sensitivity is increased using concentration techniques, such as Knott's concentration or Nuclepore membrane filtration. However, due to the small size of <em>M. perstans</em> microfilariae, membranes with a 3 mcm pore size are optimal.</p><p>Adult worms range in length from 3.5 to 4.5 cm for males and 5 to 8 cm for females. Both are no more than 120 mcm wide. Microfilariae of <em>M. perstans</em> are unsheathed and measure 190 to 200 mcm long in stained blood smears. A round terminal nucleus is found at the tip of the tail, which is blunted (<a class="graphic graphic_picture graphicRef83928" href="/d/graphic/83928.html" rel="external">picture 1</a>).</p><p><em>M. perstans</em> has been shown to have a weak diurnal periodicity with peak counts at 8:00 AM [<a href="#rid12">12</a>]. This coincides with the feeding pattern of the vector, thereby potentiating transmission of infection. Their presence in the bloodstream at all times during the day can cause them to be mistaken for microfilariae of <em>L. loa</em> or <em>Wuchereria bancrofti</em>, filarial parasites that overlap in geographic distribution with <em>M. perstans</em>.</p><p class="headingAnchor" id="H4462419"><span class="h3">Serology and other tests</span><span class="headingEndMark"> — </span>Serologic tests based on crude filarial antigens are positive in <em>M. perstans</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>A real-time polymerase chain reaction assay has been developed at the Laboratory of Parasitic Diseases, National Institutes of Health, that can detect and quantitate <em>M. perstans</em> microfilaremia [<a href="#rid13">13</a>]. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (<a class="__cf_email__" data-cfemail="3a5e4a5e427a595e59145d554c" href="/cdn-cgi/l/email-protection">[email protected]</a>) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class="headingAnchor" id="H942225774"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span><em>M. perstans</em> infection is typically diagnosed in an asymptomatic patient as an incidental finding on a blood smear or during evaluation for other filarial infections. As such, the differential diagnosis is broad and includes all causes of unexplained eosinophilia. (See  <a class="medical medical_review" href="/d/html/5691.html" rel="external">"Approach to the patient with unexplained eosinophilia"</a>.)</p><p>The differential diagnosis for symptomatic presentation depends on the specific clinical manifestations. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6698.html" rel="external">"Pleural fluid analysis in adults with a pleural effusion"</a>.)</p><p>Angioedema and eye findings can be similar to those seen in loiasis. (See  <a class="medical medical_review" href="/d/html/5684.html" rel="external">"Loiasis (Loa loa infection)"</a>.)</p><p class="headingAnchor" id="H4462433"><span class="h2">Treatment</span><span class="headingEndMark"> — </span><em>M. perstans</em> is relatively resistant to standard antifilarial agents, including <a class="drug drug_general" data-topicid="112050" href="/d/drug information/112050.html" rel="external">diethylcarbamazine</a> (DEC), <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a>, <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a>, and <a class="drug drug_general" data-topicid="9594" href="/d/drug information/9594.html" rel="external">mebendazole</a> [<a href="#rid2">2,14</a>]. In one study that compared the efficacy of multiple regimens, the best efficacy was observed with a combination of diethylcarbamazine and mebendazole administered for 21 days (37 percent microfilarial clearance at 1 month) [<a href="#rid14">14</a>].</p><p>The intracellular endosymbiont <em>Wolbachia</em> has been demonstrated in <em>M. perstans</em> from Mali, Cameroon, and Ghana but appears to be absent in parasites from Uganda and Gabon. <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">Doxycycline</a> (200 mg daily for six weeks), which has activity against <em>Wolbachia</em>, has been shown to be 100 percent effective in clearing <em>M. perstans</em> microfilariae from the blood of infected individuals in Mali for up to 36 months [<a href="#rid15">15</a>] and in Ghana for at least 24 months [<a href="#rid16">16</a>]. </p><p>The utility of <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> in the treatment of <em>M. perstans</em> from other geographic regions has not been explored; cases of imported <em>M. perstans</em> infection treated successfully with doxycycline have been reported [<a href="#rid17">17,18</a>]. </p><p class="headingAnchor" id="H4462440"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>There have been no studies of chemoprophylaxis against <em>M. perstans</em> infection. Personal protection measures to limit contact with biting midges may have some utility in individual travelers. Repeated mass drug administration using <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> has led to a modest decrease in prevalence in some endemic areas [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H4462447"><span class="h1">MANSONELLA OZZARDI</span></p><p class="headingAnchor" id="H4462455"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span><em>M. ozzardi</em> is endemic in Central America, South America (Argentina, Bolivia, Brazil, Colombia, Guyana, Suriname, and Venezuela), and the Caribbean islands (Antigua, Dominican Republic, Guadeloupe, Haiti, Martinique, Nevis, Puerto Rico, St. Kitts, St. Lucia, St. Vincent, and Trinidad). The overall prevalence of <em>M. ozzardi</em> infection is unknown; up to 70 percent of the residents in endemic foci may have parasites detectable in the blood. A study of blood donors in an endemic area of Brazil found evidence of infection by polymerase chain reaction (PCR) in 23.8 percent of donors [<a href="#rid20">20</a>]. Infection of travelers is uncommon but does occur [<a href="#rid6">6</a>]. Nonhuman primates can be infected experimentally, but humans are the only major reservoir of infection.</p><p><em>M. ozzardi</em> is transmitted by biting midges (<em>Culicoides</em>) and blackflies (<em>Simulium amazonicum</em>). The life cycle is identical to that of <em>M. perstans</em> (<a class="graphic graphic_figure graphicRef83929" href="/d/graphic/83929.html" rel="external">figure 4</a>), except that adult worms are found in the lymphatics as well as the thoracic and peritoneal cavities, and microfilariae are found both in the blood and the skin [<a href="#rid21">21</a>]. The lifespan of the adult worms is unknown.</p><p class="headingAnchor" id="H4462469"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Most individuals with <em>M. ozzardi</em> infection are asymptomatic, although urticaria, pruritic skin eruptions, edema, lymphadenopathy, arthralgias, fever, headache, vertigo, and pulmonary symptoms have been reported [<a href="#rid22">22,23</a>]. An association between <em>M. ozzardi</em> microfilaremia and nummular keratitis has also been reported in the Amazonas region of Brazil [<a href="#rid24">24</a>]. Eosinophilia is common.</p><p class="headingAnchor" id="H4462476"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span><em>M. ozzardi</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, consistent clinical findings, and/or unexplained eosinophilia. The definitive diagnosis is established by identifying the microfilariae in the blood or skin. Serology may also be useful.</p><p class="headingAnchor" id="H4462483"><span class="h3">Visualizing organisms</span><span class="headingEndMark"> — </span>The diagnosis of <em>M. ozzardi</em> infection can be definitively established by detecting microfilariae in a blood smear (<a class="graphic graphic_picture graphicRef83930" href="/d/graphic/83930.html" rel="external">picture 2</a>) or skin snips (1 mm skin biopsies obtained using a corneoscleral punch or needle and scalpel that are incubated for 30 minutes to 24 hours in <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> and examined under low magnification for the presence of motile microfilariae). Adult worms are rarely identified in tissue specimens. Concentration techniques, such as Knott's concentration or Nuclepore membrane filtration, can be useful in increasing the sensitivity of detection of blood microfilariae.</p><p>Adult female worms range in length 6.5 to 8.1 cm and up to 250 mcm wide. No intact male worms have been obtained to date. Microfilariae of <em>M. ozzardi</em> are unsheathed and measure 170 to 240 microns long in stained blood smears. They have a cephalic space that is 2 to 6 microns long with two to three overlapping nuclei and caudal space that is 3 to 8 mcm long with oval terminal nuclei (<a class="graphic graphic_picture graphicRef83930" href="/d/graphic/83930.html" rel="external">picture 2</a>).</p><p class="headingAnchor" id="H4462490"><span class="h3">Serology and other tests</span><span class="headingEndMark"> — </span>Serologic tests based on crude filarial antigens are positive in <em>M. ozzardi</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>PCR assays have been developed but are not routinely available outside of research laboratories. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (<a class="__cf_email__" data-cfemail="8febffebf7cfecebeca1e8e0f9" href="/cdn-cgi/l/email-protection">[email protected]</a>) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class="headingAnchor" id="H942225827"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The rash of <em>M. ozzardi</em> infection closely resembles that of onchocerciasis, which, until recently, was coendemic in many areas in Central and South America. With the success of the Onchocerciasis Control Program, however, the only remaining areas endemic for onchocerciasis are in the remote border area between Venezuela and Brazil. (See  <a class="medical medical_review" href="/d/html/5683.html" rel="external">"Onchocerciasis"</a>.)</p><p>Most patients present with asymptomatic eosinophilia or nonspecific symptoms, including urticaria and pruritus, which have a broad differential diagnosis. (See  <a class="medical medical_review" href="/d/html/5691.html" rel="external">"Approach to the patient with unexplained eosinophilia"</a> and  <a class="medical medical_review" href="/d/html/8101.html" rel="external">"New-onset urticaria"</a>.)</p><p class="headingAnchor" id="H4462504"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>The treatment of choice for <em>M. ozzardi</em> infection is <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> (150 mcg/kg orally). In a randomized trial including more than 40 patients with microfilaremia in Brazil treated with ivermectin or placebo, microfilarial counts on day 3 became undetectable among patients treated with ivermectin in 95 percent of cases; in the placebo group, the average microfilaremia fell from 88 to 25 mf/mL by day 3 [<a href="#rid25">25</a>]. </p><p>Other antifilarial therapies, including <a class="drug drug_general" data-topicid="112050" href="/d/drug information/112050.html" rel="external">diethylcarbamazine</a> and <a class="drug drug_general" data-topicid="9371" href="/d/drug information/9371.html" rel="external">albendazole</a> [<a href="#rid26">26</a>], appear to be ineffective. Although <em>M. ozzardi</em> does harbor the intracellular endosymbiont <em>Wolbachia</em> [<a href="#rid27">27</a>], there are no published studies of <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> or other antibacterial therapies to date.</p><p class="headingAnchor" id="H4462511"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>There have been no studies of chemoprophylaxis against <em>M. ozzardi</em> infection. Personal protection measures to limit contact with biting midges and blackflies may have some utility in individual travelers.</p><p class="headingAnchor" id="H4462518"><span class="h1">MANSONELLA STREPTOCERCA</span></p><p class="headingAnchor" id="H4462526"><span class="h2">Epidemiology</span><span class="headingEndMark"> — </span><em>M. streptocerca</em> is endemic in the tropical rain forests of western and central Africa, including northern Angola, Cameroon, Central African Republic, Democratic Republic of Congo, Equatorial Guinea, Nigeria, People's Republic of Congo, and western Uganda. The prevalence of <em>M. streptocerca</em> infection is unknown; up to 90 percent of the residents in endemic foci may be infected. Infection of travelers is uncommon but does occur [<a href="#rid6">6</a>]. Nonhuman primates are occasionally infected but do not appear to be a major reservoir of infection.</p><p>The life cycle is identical to that of <em>M. perstans</em> (<a class="graphic graphic_figure graphicRef82920" href="/d/graphic/82920.html" rel="external">figure 3</a>) except that adult worms reside in the dermis of the upper trunk and shoulder girdle and that microfilariae are found in the skin. The lifespan of the adult worms is unknown. <em>M. streptocerca</em> is transmitted by biting midges (<em>Culicoides</em>).</p><p class="headingAnchor" id="H4462540"><span class="h2">Clinical manifestations</span><span class="headingEndMark"> — </span>Most individuals with <em>M. streptocerca</em> infection are asymptomatic. The most common complaint is pruritus, especially over the shoulder girdle and thorax [<a href="#rid28">28</a>]. Dermal thickening, nonanesthetic hypopigmented macules, and bilateral axillary or inguinal lymphadenopathy have been described. Unlike <em>O. volvulus</em>, the adult worms do not form subcutaneous nodules. Eosinophilia is common.</p><p class="headingAnchor" id="H4462547"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span><em>M. streptocerca</em> infection should be suspected in an individual with an appropriate epidemiologic exposure, pruritus, a macular hypopigmented rash or lymphadenopathy, and/or unexplained eosinophilia. The definitive diagnosis is established by identifying the microfilariae in the skin. Serology may also be useful.</p><p class="headingAnchor" id="H4462554"><span class="h3">Visualizing organisms</span><span class="headingEndMark"> — </span>The diagnosis of <em>M. streptocerca</em> infection can be definitively established by detecting microfilariae in skin snips. Reports of adult worms identified in tissue biopsies are extremely few.</p><p>Adult worms are approximately 1.7 cm by 50 mcm for males and 2.7 cm by 85 mcm for females. Microfilariae of <em>M. streptocerca</em> are unsheathed, 180 to 240 mcm long, and have a characteristic sharp curve in the posterior end that is reminiscent of a shepherd's crook (<a class="graphic graphic_picture graphicRef83931" href="/d/graphic/83931.html" rel="external">picture 3</a>). This unusual feature allows an experienced technician to distinguish <em>M. streptocerca</em> from <em>O. volvulus</em> microfilariae without special staining.</p><p class="headingAnchor" id="H4462561"><span class="h3">Serology and other tests</span><span class="headingEndMark"> — </span>Serologic tests based on crude filarial antigens are positive in <em>M. streptocerca</em> infection but do not distinguish between active or past infection and show cross-reactivity between the different filarial species and with other nematode infections. Consequently, their utility is limited, although a negative result can exclude the possibility of infection.</p><p>Polymerase chain reaction assays have been developed but are not routinely available outside of research laboratories [<a href="#rid29">29</a>]. Assistance with serologic and other diagnostic tests is available from the United States Centers for Disease Control and Prevention (<a class="__cf_email__" data-cfemail="85e1f5e1fdc5e6e1e6abe2eaf3" href="/cdn-cgi/l/email-protection">[email protected]</a>) and the Laboratory of Parasitic Diseases, National Institutes of Health (301-496-5398).</p><p class="headingAnchor" id="H942225882"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The pruritic rash of <em>M. streptocerca</em> resembles that of onchocerciasis, which is coendemic in many parts of Africa. Nonpruritic hypopigmented lesions seen in onchocerciasis (leopard skin) are smaller than the hypopigmented macules in <em>M. streptocerca</em> infection. Other diseases that must be distinguished include leprosy and tinea. As with the other <em>Mansonella</em> infections, most patients are asymptomatic and are detected incidentally because of eosinophilia. (See  <a class="medical medical_review" href="/d/html/5683.html" rel="external">"Onchocerciasis"</a> and  <a class="medical medical_review" href="/d/html/5348.html" rel="external">"Leprosy: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4030.html" rel="external">"Dermatophyte (tinea) infections"</a> and  <a class="medical medical_review" href="/d/html/5691.html" rel="external">"Approach to the patient with unexplained eosinophilia"</a>.)</p><p class="headingAnchor" id="H4462575"><span class="h2">Treatment</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="112050" href="/d/drug information/112050.html" rel="external">Diethylcarbamazine</a> (DEC; 6 mg/kg/day for 12 days) is effective for the treatment of <em>M. streptocerca</em> infection and kills both microfilariae and the adult worms, although treatment can be accompanied by exacerbation of clinical symptoms including pruritus, papular eruptions, arthralgias, fever, myalgias, headache, nausea, and vomiting. Furthermore, DEC should not be administered to patients for whom concomitant onchocerciasis cannot be excluded, due to the provocation of serious side effects, including exacerbation of ocular disease. <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">Ivermectin</a> (150 mcg/kg as a single dose) is useful in reducing microfilarial loads [<a href="#rid30">30</a>], although the clinical effects of ivermectin in streptocerciasis are unknown. Neither the presence of <em>Wolbachia</em> nor the utility of <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> in the treatment of <em>M. streptocerca</em> have been explored to date.</p><p class="headingAnchor" id="H4462582"><span class="h2">Prevention</span><span class="headingEndMark"> — </span>There have been no studies of chemoprophylaxis against <em>M. streptocerca</em> infection. Personal protection measures to limit contact with biting midges may have some utility in individual travelers.</p><p class="headingAnchor" id="H4462589"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>There are three species of <em>Mansonella</em> that cause human infections: <em>M. streptocerca</em>, <em>M. perstans</em>, and <em>M. ozzardi</em>. A potential fourth species, <em>Mansonella</em> spp "DEUX" has been described in Gabon. <em>Mansonella </em>infections are frequently asymptomatic but may complicate diagnosis and treatment of other human filarial infections that overlap in geographic distribution and clinical manifestations. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The epidemiology, clinical manifestations, diagnosis, and treatment vary between <em>Mansonella</em> species and are outlined in the table (<a class="graphic graphic_table graphicRef66052 graphicRef70668" href="/d/graphic/66052.html" rel="external">table 1A-B</a>). (See <a class="local">'Mansonella perstans'</a> above and <a class="local">'Mansonella ozzardi'</a> above and <a class="local">'Mansonella streptocerca'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sandri TL, Kreidenweiss A, Cavallo S, et al. Molecular Epidemiology of Mansonella Species in Gabon. J Infect Dis 2021; 223:287.</a></li><li><a class="nounderline abstract_t">Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop 2011; 120 Suppl 1:S109.</a></li><li><a class="nounderline abstract_t">Marcos LA, Arrospide N, Recuenco S, et al. Genetic characterization of atypical Mansonella (Mansonella) ozzardi microfilariae in human blood samples from northeastern Peru. Am J Trop Med Hyg 2012; 87:491.</a></li><li><a class="nounderline abstract_t">Ta-Tang TH, Luz SL, Merino FJ, et al. Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia. Am J Trop Med Hyg 2016; 95:629.</a></li><li><a class="nounderline abstract_t">Crainey JL, Costa CHA, de Oliveira Leles LF, et al. Deep Sequencing Reveals Occult Mansonellosis Coinfections in Residents From the Brazilian Amazon Village of São Gabriel da Cachoeira. Clin Infect Dis 2020; 71:1990.</a></li><li><a class="nounderline abstract_t">Lipner EM, Law MA, Barnett E, et al. Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl Trop Dis 2007; 1:e88.</a></li><li><a class="nounderline abstract_t">Tamarozzi F, Rodari P, Salas-Coronas J, et al. A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe. J Travel Med 2022; 29.</a></li><li><a class="nounderline abstract_t">Pongui Ngondza B, Koumba Lengongo JV, Mickala P, et al. Prevalence and risk factors for blood filariasis among HIV-infected adults in Gabon, Central Africa: a pilot study. Trans R Soc Trop Med Hyg 2022; 116:1015.</a></li><li><a class="nounderline abstract_t">Kiefer G, Battegay M, Gyr N, Hatz C. [Mansonella perstans filariasis after stay in Cameroon. A 19-year-old patient born in Cameroon, in Switzerland for the last 10 years]. Praxis (Bern 1994) 2002; 91:61.</a></li><li><a class="nounderline abstract_t">Bottieau E, Huits R, Van Den Broucke S, et al. Human Filariasis in Travelers and Migrants: A Retrospective 25-year Analysis at the Institute of Tropical Medicine, Antwerp, Belgium. Clin Infect Dis 2022; 74:1972.</a></li><li><a class="nounderline abstract_t">Puente S, Lago M, Subirats M, et al. Imported Mansonella perstans infection in Spain. Infect Dis Poverty 2020; 9:105.</a></li><li><a class="nounderline abstract_t">Asio SM, Simonsen PE, Onapa AW. Analysis of the 24-h microfilarial periodicity of Mansonella perstans. Parasitol Res 2009; 104:945.</a></li><li><a class="nounderline abstract_t">Keiser PB, Coulibaly Y, Kubofcik J, et al. Molecular identification of Wolbachia from the filarial nematode Mansonella perstans. Mol Biochem Parasitol 2008; 160:123.</a></li><li><a class="nounderline abstract_t">Bregani ER, Rovellini A, Mbaïdoum N, Magnini MG. Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis. Trans R Soc Trop Med Hyg 2006; 100:458.</a></li><li><a class="nounderline abstract_t">Coulibaly YI, Dembele B, Diallo AA, et al. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 2009; 361:1448.</a></li><li><a class="nounderline abstract_t">Batsa Debrah L, Phillips RO, Pfarr K, et al. The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana. Am J Trop Med Hyg 2019; 101:84.</a></li><li><a class="nounderline abstract_t">Asgeirsson H, Harling A, Botero-Kleiven S. Successful treatment of 2 imported cases of Mansonella perstans infection. PLoS Negl Trop Dis 2017; 11:e0005452.</a></li><li><a class="nounderline abstract_t">Gobbi F, Beltrame A, Buonfrate D, et al. Imported Infections with Mansonella perstans Nematodes, Italy. Emerg Infect Dis 2017; 23:1539.</a></li><li><a class="nounderline abstract_t">Wanji S, Tayong DB, Layland LE, et al. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin. Parasit Vectors 2016; 9:311.</a></li><li><a class="nounderline abstract_t">Abrahim CMM, Py-Daniel V, Luz SLB, et al. Detection of Mansonella ozzardi among blood donors from highly endemic interior cities of Amazonas state, northern Brazil. Transfusion 2019; 59:1044.</a></li><li><a class="nounderline abstract_t">Nathan MB, Bartholomew CF, Tikasingh ES. The detection of Mansonella ozzardi microfilariae in the skin and blood with a note on the absence of periodicity. Trans R Soc Trop Med Hyg 1978; 72:420.</a></li><li class="breakAll">Klion A, Nutman TB. Loiasis and Mansonella Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant R, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.735.</li><li><a class="nounderline abstract_t">Bartoloni A, Cancrini G, Bartalesi F, et al. Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region. Am J Trop Med Hyg 1999; 61:830.</a></li><li><a class="nounderline abstract_t">Vianna LM, Martins M, Cohen MJ, et al. Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study. BMJ Open 2012; 2.</a></li><li><a class="nounderline abstract_t">de Almeida Basano S, de Souza Almeida Aranha Camargo J, Fontes G, et al. Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of Mansonella ozzardi infection in the Brazilian Amazon. Am J Trop Med Hyg 2018; 98:786.</a></li><li><a class="nounderline abstract_t">Bartholomew CF, Nathan MB, Tikasingh ES. The failure of diethylcarbamazine in the treatment of Mansonella ozzardi infections. Trans R Soc Trop Med Hyg 1978; 72:423.</a></li><li><a class="nounderline abstract_t">Casiraghi M, Favia G, Cancrini G, et al. Molecular identification of Wolbachia from the filarial nematode Mansonella ozzardi. Parasitol Res 2001; 87:417.</a></li><li><a class="nounderline abstract_t">Fischer P, Bamuhiiga J, Büttner DW. Occurrence and diagnosis of Mansonella streptocerca in Uganda. Acta Trop 1997; 63:43.</a></li><li><a class="nounderline abstract_t">Fischer P, Büttner DW, Bamuhiiga J, Williams SA. Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay. Am J Trop Med Hyg 1998; 58:816.</a></li><li><a class="nounderline abstract_t">Fischer P, Tukesiga E, Büttner DW. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin. J Infect Dis 1999; 180:1403.</a></li></ol></div><div id="topicVersionRevision">Topic 83819 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33099649" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Molecular Epidemiology of Mansonella Species in Gabon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20152790" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Mansonella perstans filariasis in Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22826497" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Genetic characterization of atypical Mansonella (Mansonella) ozzardi microfilariae in human blood samples from northeastern Peru.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27402517" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31995172" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Deep Sequencing Reveals Occult Mansonellosis Coinfections in Residents From the Brazilian Amazon Village of São Gabriel da Cachoeira.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18160987" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Filariasis in travelers presenting to the GeoSentinel Surveillance Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35417002" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35474144" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence and risk factors for blood filariasis among HIV-infected adults in Gabon, Central Africa: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11845614" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : [Mansonella perstans filariasis after stay in Cameroon. A 19-year-old patient born in Cameroon, in Switzerland for the last 10 years].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34463732" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Human Filariasis in Travelers and Migrants: A Retrospective 25-year Analysis at the Institute of Tropical Medicine, Antwerp, Belgium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32703283" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Imported Mansonella perstans infection in Spain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19107522" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Analysis of the 24-h microfilarial periodicity of Mansonella perstans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18538871" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Molecular identification of Wolbachia from the filarial nematode Mansonella perstans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16257021" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19812401" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A randomized trial of doxycycline for Mansonella perstans infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31162017" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28542192" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Successful treatment of 2 imported cases of Mansonella perstans infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28820369" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Imported Infections with Mansonella perstans Nematodes, Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27245442" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30566229" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Detection of Mansonella ozzardi among blood donors from highly endemic interior cities of Amazonas state, northern Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/360501" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The detection of Mansonella ozzardi microfilariae in the skin and blood with a note on the absence of periodicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/360501" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The detection of Mansonella ozzardi microfilariae in the skin and blood with a note on the absence of periodicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586920" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23187969" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29313486" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of Mansonella ozzardi infection in the Brazilian Amazon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/360502" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The failure of diethylcarbamazine in the treatment of Mansonella ozzardi infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11403387" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Molecular identification of Wolbachia from the filarial nematode Mansonella ozzardi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9083584" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Occurrence and diagnosis of Mansonella streptocerca in Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9660471" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Detection of the filarial parasite Mansonella streptocerca in skin biopsies by a nested polymerase chain reaction-based assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10479183" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
